Evidence map›Paper›PMID 31059499›Full record

ArticlePLoS genetics2019

Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy.

Karina Vázquez-Arreguín, Claire Bensard, John C Schell, Eric Swanson, Xinjian Chen, Jared Rutter, Dean Tantin

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of animal hosts in shaping gut microbiome variation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Karina Vázquez-ArreguínDepartment of Pathology and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Claire BensardDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, United States of America.ORCID 0000-0003-0366-5270
John C SchellDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Eric SwansonDepartment of Pathology and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Xinjian ChenDepartment of Pathology and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Jared RutterDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Dean TantinDepartment of Pathology and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, United States of America.ORCID 0000-0003-1354-8385
University of Utah · USHoward Hughes Medical Institute · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
Role of Transcription Coactivator OCA-B in Gene Poising and Immunological MemoryR01AI100873 · NIAID · UNIVERSITY OF UTAH · PI TANTIN, DEAN · 2013 to 2022
$3.8M
Metabolic regulation of intestinal stem cell homeostasisR01CA228346 · NCI · UNIVERSITY OF UTAH · PI RUTTER, JARED P, THUMMEL, CARL S. · 2018 to 2022
$2.3M
Developmental gene poising by Oct transcription factorsR01GM122778 · NIGMS · UNIVERSITY OF UTAH · PI TANTIN, DEAN · 2018 to 2021
$1.2M
Investigating the role of the mitochondrial pyruvate carrier in colon tumorigenesisF30CA225110 · NCI · UNIVERSITY OF UTAH · PI BENSARD, CLAIRE · 2018 to 2021
$171k
NCI NIH HHS F30 CA225110NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA228346NIAID NIH HHS R01 AI100873NIDDK NIH HHS T32 DK091317NIGMS NIH HHS R01 GM122778
6 · The paper itself

Abstract

The transcription factor Oct1/Pou2f1 promotes poised gene expression states, mitotic stability, glycolytic metabolism and other characteristics of stem cell potency. To determine the effect of Oct1 loss on stem cell maintenance and malignancy, we deleted Oct1 in two different mouse gut stem cell compartments. Oct1 deletion preserved homeostasis in vivo and the ability to establish organoids in vitro, but blocked the ability to recover from treatment with dextran sodium sulfate, and the ability to maintain organoids after passage. In a chemical model of colon cancer, loss of Oct1 in the colon severely restricted tumorigenicity. In contrast, loss of one or both Oct1 alleles progressively increased tumor burden in a colon cancer model driven by loss-of-heterozygosity of the tumor suppressor gene Apc. The different outcomes are consistent with prior findings that Oct1 promotes mitotic stability, and consistent with differentially expressed genes between the two models. Oct1 ChIPseq using HCT116 colon carcinoma cells identifies target genes associated with mitotic stability, metabolism, stress response and malignancy. This set of gene targets overlaps significantly with genes differentially expressed in the two tumor models. These results reveal that Oct1 is selectively required for recovery after colon damage, and that Oct1 has potent effects in colon malignancy, with outcome (pro-oncogenic or tumor suppressive) dictated by tumor etiology.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAzoxymethaneCarcinogenesisColonColonic NeoplasmsDextran SulfateDisease Models, AnimalFemaleGene Expression ProfilingHCT116 CellsHumansIntegrasesIntestine, SmallMiceMice, KnockoutAzoxymethaneCre recombinaseDextran SulfateIntegrasesLgr5 protein, mouseOctamer Transcription Factor-1Pou2f1 protein, mouseReceptors, G-Protein-CoupledTamoxifen

Identifiers

PMID31059499
PMCPMC6522070
OpenAlexW2943117787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.